Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6)

Department of General Internal Medicine, Hiroshima University, Hirosima, Hiroshima, Japan
Human Molecular Genetics (Impact Factor: 6.39). 08/1997; 6(8):1283-7. DOI: 10.1093/hmg/6.8.1283
Source: PubMed


Spinocerebellar ataxia 6 (SCA6) is an autosomal dominant spinocerebellar degeneration caused by the expansion of the polymorphic CAG repeat in the human alpha1A voltage-dependent calcium channel subunit gene (CACNL1A4 gene). We have analyzed 60 SCA6 individuals from 39 independent SCA6 Japanese families and found that the CAG repeat length is inversely correlated with the age of onset (n = 58, r = -0.51, P < 0.0001). SCA6 chromosomes contained 21-30 repeat units, whereas normal chromosomes displayed 6-17 repeats. There was no overlap between the normal and affected CAG repeat number. The anticipation of the disease was observed clinically in all eight parent-child pairs that we examined; the mean age of onset was significantly lower (P = 0.0042) in children than in parents. However, a parent-child analysis showed the increase in the expansion of CAG repeats only in one pair and no diminution in any affected cases. This result suggests that factors other than CAG repeats may produce the clinical anticipation. A homozygotic case could not demonstrate an unequivocal gene dosage effect on the age of onset.

Download full-text


Available from: Yuishin Izumi, Sep 19, 2015
  • Source
    • "SCA3 Standard PCR Kawaguchi et al., 1994 160bp þ 3n (n ¼ number of CAG repeats). SCA6 Standard PCR Matsuyama et al., 1997 102bp þ 3n (n ¼ number of CAG repeats). SCA7 Standard PCR David et al., 1997 272bp þ 3n (n ¼ number of CAG repeats). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Trinucleotide repeat disorders (TRDs) are a set of genetic disorders caused by trinucleotide repeat expansion in certain genes that exceed the normal, stable threshold, which varies from gene to gene. A dynamic mutation in a healthy gene may increase the repeat count and result in a defective gene. At present there are 14 pathogenic trinucleotide repeat disorders that are known to affect humans. The occurrence of these “triplet repeat diseases” within populations ranges from fairly common (Fragile X syndrome and myotonic dystrophy type 1) to rare (Dentatorubral-pallidoluysian atrophy). In the present study we report a detailed scenario of TRDs in India mostly in respect to the 9 most common disorders namely; Fragile X syndrome, Myotonic dystrophy type 1, Spinocerebellar ataxia (type 1, 2, 3, 6 and 7), Friedreich's Ataxia and Huntington Disease.
    European Journal of Medical Genetics 12/2014; 58(3):160-167. DOI:10.1016/j.ejmg.2014.12.010 · 1.47 Impact Factor
    • "This is known as dynamic mutation. SCA 6 and SCA 17 are the exceptions where number of CAG repeats remains stable in subsequent generations.[1011] "
    [Show abstract] [Hide abstract]
    ABSTRACT: The dominantly inherited ataxias, also known as Spino-cerebellar ataxias (SCAs), are rapidly expanding entities. New mutations are being identified at remarkable regularity. Recent awareness of molecular abnormalities in SCAs has addressed some of the long sought questions, but gaps in knowledge still exist. Three major categories of SCAs, according to molecular mechanisms, have evolved over recent few years: Polyglutamate expansion ataxia, non-coding zone repeat ataxia, and ataxia due to conventional mutation. Using the fulcrum of these mechanisms, the article provides an update of SCAs. Shared and specific clinical features, genetic abnormalities, and possible links between molecular abnormalities and cerebellar degeneration have been discussed. Emphasis has been placed on the mechanisms of polyglutamate toxicity.
    Annals of Indian Academy of Neurology 03/2013; 16(3):295-303. DOI:10.4103/0972-2327.116896 · 0.60 Impact Factor
  • Source
    • "As the mutation of SCA6 is in CACNA1A encoding Cav2.1, a pore-forming subunit of P/Q-type voltage-dependent calcium channel essential for neurons [4, 30, 55], it is possible that such small polyQ expansion leads to neurodegeneration by functional alterations of Cav2.1 [5, 14, 21, 28, 35, 36, 50]. However, two recent studies on different SCA6 knock-in mice neither found that expanded polyQ affects the electrophysiological properties of Cav2.1 [37, 57], suggesting that the pathogenic mechanism of polyQ expansion in SCA6 is not merely due to functional changes of Cav2.1. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Spinocerebellar ataxia type 6 (SCA6) is an autosomal dominant neurodegenerative disease caused by a small polyglutamine (polyQ) expansion (control: 4-20Q; SCA6: 20-33Q) in the carboxyl(C)-terminal cytoplasmic domain of the alpha(1A) voltage-dependent calcium channel (Ca(v)2.1). Although a 75-85-kDa Ca(v)2.1 C-terminal fragment (CTF) is toxic in cultured cells, its existence in human brains and its role in SCA6 pathogenesis remains unknown. Here, we investigated whether the small polyQ expansion alters the expression pattern and intracellular distribution of Ca(v)2.1 in human SCA6 brains. New antibodies against the Ca(v)2.1 C-terminus were used in immunoblotting and immunohistochemistry. In the cerebella of six control individuals, the CTF was detected in sucrose- and SDS-soluble cytosolic fractions; in the cerebella of two SCA6 patients, it was additionally detected in SDS-insoluble cytosolic and sucrose-soluble nuclear fractions. In contrast, however, the CTF was not detected either in the nuclear fraction or in the SDS-insoluble cytosolic fraction of SCA6 extracerebellar tissues, indicating that the CTF being insoluble in the cytoplasm or mislocalized to the nucleus only in the SCA6 cerebellum. Immunohistochemistry revealed abundant aggregates in cell bodies and dendrites of SCA6 Purkinje cells (seven patients) but not in controls (n = 6). Recombinant CTF with a small polyQ expansion (rCTF-Q28) aggregated in cultured PC12 cells, but neither rCTF-Q13 (normal-length polyQ) nor full-length Ca(v)2.1 with Q28 did. We conclude that SCA6 pathogenesis may be associated with the CTF, normally found in the cytoplasm, being aggregated in the cytoplasm and additionally distributed in the nucleus.
    Acta Neuropathologica 04/2010; 119(4):447-64. DOI:10.1007/s00401-009-0630-0 · 10.76 Impact Factor
Show more